Joint replacements are the #1 expenditure of Medicare. The process of approving these medical devices is flawed according to the Institute of Medicine. It is time for patients' voices to be heard as stakeholders and for public support for increased medical device industry accountability and heightened protections for patients. Post-market registry. Product warranty. Patient/consumer stakeholder equity. Rescind industry pre-emptions/entitlements. All clinical trials must report all data.
Please share what you have learned!
Twitter: @JjrkCh

Tuesday, October 18, 2011

Device Data and essential Patient Rights

Hugo Campos serenades Medtronic in this YouTube video. (link)

(video link) Hugo Campos at Patient 2.0 in SF 9/25/11

He is talking about basic citizen rights!  Please help him by communicating this issue to your U.S. Representatives today.

Hugo was a fellow speaker at the FDA SF Town Hall meeting 9/22/11 and the Health 2.0 conference in SF.
Dr. Jeffrey Shuren (FDA/CDRH Director) agrees with Hugo that patient data should belong to the patient!


No comments:

Post a Comment